Accessibility Menu
 
Oncologix Tech logo

Oncologix Tech

(OTC) OCLG

Current Price$0.00
Market Cap$1,700
Since IPO (1992)-100%
5 Year-100%
1 Year-99%
1 Month-99%

Oncologix Tech Financials at a Glance

Market Cap

$1,700

Revenue (TTM)

$2.16M

Net Income (TTM)

$1.73M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

26.18 (High)

Price

$0.00

Volume

7,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

OCLG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncologix Tech

Industry

Healthcare Providers and Services

CEO

Frank Ikechukwu Igwealor, MBA, CPA

Headquarters

Lafayette, LA 70508, US

OCLG Financials

Key Financial Metrics (TTM)

Gross Margin

20%

Operating Margin

-30%

Net Income Margin

-83%

Return on Equity

0%

Return on Capital

0%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.70K

Shares Outstanding

1.66B

Volume

7.50K

Avg. Volume

1.71K

Financials (TTM)

Gross Profit

$571.56K

Operating Income

$865.00K

EBITDA

$1.11M

Operating Cash Flow

$24.20K

Capital Expenditure

$913.00

Free Cash Flow

$25.12K

Cash & ST Invst.

$0.00

Total Debt

$0.00

Oncologix Tech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.70K

N/A

Market Cap/Employee

$8.90

N/A

Employees

191

N/A

Net Income

$18.77K

+96.8%

EBITDA

$18.77K

+95.2%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Net Cash

$18.77K

+99.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$23.62K

-94.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

$18.77K

+90.5%

Operating Cash Flow

$18.77K

+90.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CGSICGS International, Inc.
$0.00+0.00%
PLKTSolar Gold Ltd.
$0.00+0.00%
BISABaltic International USA, Inc.
$0.00+0.00%
OHCSOptimus Healthcare Services, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About OCLG

What is the current price of Oncologix Tech?

Oncologix Tech is trading at N/A per share.

What is the 52-week range for Oncologix Tech?

Over the past 52 weeks, Oncologix Tech has traded between N/A and $0.00.

How much debt does Oncologix Tech have?

As of the most recent reporting period, Oncologix Tech reported total debt of N/A.

How much cash does Oncologix Tech have on hand?

Oncologix Tech reported N/A in cash and cash equivalents in its most recent financial results.

What is Oncologix Tech’s dividend yield?

Oncologix Tech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.